Rubella pada Kehamilan

01Pathophysiology

Rubella virus belongs to the Togaviridae family and is transmitted via respiratory droplets. When a non-immune pregnant woman contracts rubella, the virus enters the bloodstream and crosses the placenta during the period of maternal viremia. The virus has a particular tropism for rapidly dividing fetal cells, which explains why the damage is most severe during organogenesis in the first trimester.

The mechanism of fetal injury is twofold. First, rubella virus causes direct cytopathic damage to endothelial cells lining fetal blood vessels. This vascular injury leads to ischemic damage in developing organs, particularly the heart, eyes, and inner ear. Second, the virus inhibits cellular mitosis, reducing the total cell number in affected organs and resulting in hypoplastic organ development. This is why affected neonates frequently exhibit intrauterine growth restriction and microcephaly.

The timing of maternal infection is the single most important determinant of severity. Infection before 12 weeks of gestation carries a risk of congenital defects exceeding 80%, because this window coincides with cardiac septation, lens formation, and cochlear development. Infection between 12 and 18 weeks still carries risk, primarily for sensorineural hearing loss (the organ of Corti is among the last structures to complete differentiation). After 20 weeks, the risk of congenital defects drops substantially because organogenesis is essentially complete.

The characteristic "blueberry muffin" rash is not a viral exanthem. It represents foci of dermal extramedullary hematopoiesis, a compensatory response to rubella-induced bone marrow suppression and thrombocytopenia. This finding is not exclusive to CRS (it also appears in CMV and other TORCH infections), but in the context of the classic triad, it is highly suggestive.

Infected neonates can shed the virus for months after birth (typically up to 12 months), making them a significant source of contagion to susceptible contacts, including pregnant healthcare workers.

02Classification and Clinical Manifestation

Gregg Triad

Other Manifestations

Severity by Timing of Maternal Infection

03Diagnostic Workup

Diagnostic reasoning: The single most important initial test in a neonate suspected of CRS is rubella-specific IgM. Because IgM antibodies cannot cross the placenta, a positive neonatal IgM is direct evidence of fetal infection. This distinguishes active congenital infection from passive transfer of maternal IgG.

If IgM is equivocal or the clinical picture is ambiguous, serial IgG titers become valuable. Normally, passively transferred maternal IgG declines and disappears by 6 to 8 months of age. If the infant's rubella IgG remains elevated or fails to decline, this confirms endogenous antibody production due to congenital infection.

For definitive virologic confirmation, RT-PCR or viral isolation from nasopharyngeal secretions, urine, or lens aspirate is the most accurate method. This also has public health importance because a positive culture means the infant is actively shedding virus and must be isolated from susceptible individuals.

Organ-targeted workup (echocardiography, ABR, ophthalmologic examination) should be performed in every confirmed case, even if the presenting complaint involves only one organ system, because subclinical involvement of other systems is common.

04Management and Treatment

There is no antiviral therapy for CRS. Management is entirely supportive and multidisciplinary. The exam will almost never ask you to "treat" CRS pharmacologically. Instead, the testable angle is prevention through vaccination.

The most high-yield management concept is the pre-conception vaccination strategy. A woman found to be rubella non-immune during preconception counseling or early prenatal screening should receive MMR vaccine and be advised to avoid pregnancy for at least 4 weeks after vaccination. If a pregnant woman is found to be non-immune, she cannot be vaccinated during pregnancy because MMR is a live attenuated vaccine. She should be vaccinated immediately postpartum to protect future pregnancies.

For cardiac lesions, PDA is the most commonly tested surgical intervention. If the PDA is hemodynamically significant (wide pulse pressure, continuous "machinery" murmur, signs of heart failure), the next best step is echocardiographic confirmation followed by surgical ligation or transcatheter closure.

Early cataract removal (within the first few weeks of life) is critical to prevent irreversible deprivation amblyopia. Delay in surgery leads to permanent visual impairment even if the cataract is later removed.

05Differential Diagnosis and Distractors

The most commonly confused pair on exams is CRS vs. Congenital CMV. Both can produce hearing loss, blueberry muffin rash, hepatosplenomegaly, and microcephaly. The key discriminators are:

• Cataracts + PDA = CRS

• Chorioretinitis + periventricular calcifications = CMV

A vignette that mentions a congenital heart defect (especially PDA or pulmonary artery stenosis) alongside eye findings and deafness is pointing squarely at rubella.

06Traps and High-Yield Pearls

The most common trap with CRS questions is confusing it with congenital CMV. Both are TORCH infections with overlapping features, and the vignette may include shared findings like hepatosplenomegaly, thrombocytopenia, and hearing loss. The discriminator the test-writer plants in the stem is the type of eye finding (cataracts for rubella, chorioretinitis for CMV) and the presence of a congenital heart defect (strongly favors rubella).

Another frequently tested trap involves management of rubella exposure during pregnancy. Students sometimes select "give MMR vaccine" when a pregnant woman is exposed to rubella. This is wrong. MMR is a live vaccine and is absolutely contraindicated in pregnancy. The correct answer for a susceptible pregnant woman exposed to rubella is rubella-specific immunoglobulin (IG) for passive immunization, followed by MMR vaccination postpartum. If the vignette describes a non-immune woman who is not yet pregnant, the answer is to vaccinate now and advise contraception for at least 4 weeks.

Students also overlook the fact that sensorineural hearing loss is the single most common manifestation of CRS and may be the only finding if infection occurred in the second trimester. A vignette describing isolated bilateral sensorineural hearing loss in an infant born to a mother with a first-trimester rash illness should trigger consideration of CRS even without cardiac or ocular findings.

Finally, remember the late manifestations. CRS is not a static condition. Patients can develop insulin-dependent diabetes mellitus and thyroid disease years to decades later, presumably through autoimmune mechanisms triggered by persistent viral antigen. If a question describes a young adult with type 1 diabetes and a history of congenital cataracts or hearing loss, connect the dots back to CRS.

The core competency being tested is the ability to recognize the classic triad, correctly assign it to rubella (not CMV or toxoplasmosis), understand that prevention through vaccination is the cornerstone of management, and recall the contraindication of live vaccines in pregnancy.